ARC Innovation & Paradigm Health Inc.: A New Powerhouse Collaboration Set to Optimize Global Clinical Trials

In a game-changing, strategic move set to transform the landscape of clinical research, Sheba Medical Center, Israel’s largest hospital and a global leader in medical innovation, has joined forces with its innovation arm, ARC Innovation, and Paradigm Health Inc. The landmark partnership, officially announced during the ARC Summit 2024 at Sheba Medical Center, aims to establish a cutting-edge trial platform for clinical research, positioning the trio as pioneers in shaping the future of clinical trials.

A Vision for the Future of Clinical Trials

This strategic collaboration represents a shared commitment to revolutionizing clinical trial processes through an AI-driven platform. The innovative system is designed to:

• Optimize clinical trials by automating key processes 
• Enhance site selection, patient recruitment, engagement, and retention
• Adapt to real-time data to refine trial protocols and site selections

By shifting clinical trials from traditional academic settings to patient-centered environments closer to where patients live and receive care, the platform aims to:

• Improve inclusivity in clinical research
• Reduce costs associated with trial operations
• Accelerate the development of new therapies

This approach promises to benefit pharmaceutical companies, patients, researchers, and medical institutions alike. Patients will gain access to a broader range of advanced care options closer to home while also alleviating the operational demands on Sheba’s providers.

Expanding Capacity and Enhancing Efficiency of Trials

The integration of Paradigm’s state-of-the-art platform with Sheba and ARC’s expertise will dramatically increase trial capacity and operational efficiency. Sheba’s renowned Riva Koschitzky Oncology Clinical Research Unit, already a preferred partner for global pharmaceutical companies, will contribute to broadening Sheba’s clinical trial capabilities and help establish a network of trials across its affiliated clinics in Israel.

Benefits for Patients and Operational Efficiency

• Improved Patient Access: Patients will have more advanced care options available closer to home.
• Reduced Provider Burden: Sheba’s providers will experience a decrease in the operational load associated with study management.
• Optimized Trial Operations: The platform will enhance efficiency in trial processes, including feasibility assessments, patient screening, recruitment, and data management.
• Lower Administrative Costs: Streamlining these operations will result in reduced administrative efforts and associated costs.

Global Expansion of the Platform and AI Integration

In addition to boosting Sheba’s clinical trial capabilities, ARC plans to extend the platform to its global network of hospitals through Paradigm’s system. This clinical trial platform will standardize methodologies, enhance access to cutting-edge treatments, and expedite medical research. This expansion underscores both organizations’ dedication to advancing and optimizing clinical research worldwide.

This initiative aligns with Sheba’s commitment to becoming one of the world’s first fully-integrated AI-based hospitals. Through ARC, Sheba is leveraging data and AI solutions to enhance various aspects of healthcare, including patient care, diagnostics and personalized treatment.

Collaborating with leading institutions like the Mayo Clinic, Sheba is positioning itself at the forefront of medical innovation by integrating advanced AI solutions across its departments.

Commenting on the partnership, Prof. Eyal Zimlichman, MD, Chief Innovation and Transformation Officer at Sheba Medical Center and Founder and Director of ARC Innovation said: “Partnering with Paradigm allows us to leverage cutting-edge technologies to create a unified global network that standardizes and optimizes clinical trials, ensuring that life-saving treatments reach patients faster and more efficiently. Our co-development of the clinical trial platform of the future aligns with ARC’s mission to transform global health through innovation. With Paradigm’s cutting-edge platform, we can accelerate the pace of innovation and bring life-saving treatments to patients faster than ever before.”